首页> 中文期刊> 《科技创新导报》 >玻璃酸钠治疗II~III阶段颞下颌关节紊乱综合症的疗效分析

玻璃酸钠治疗II~III阶段颞下颌关节紊乱综合症的疗效分析

         

摘要

Study of sodium hyaluronate,2% lidocaine injection in the treatment of the clinical effect of 27 cases of II~III stage temporomandibular joint disorder syndrome analysis;specific methods:the 27 patients were arbitrarily divided into 22 cases of the experimental group and 5 cases in the control group,the former using 1ml sodium hyaluronate(10mg),2% lidocaine 0.5ml patients the injection side articular cavity,the latter with injection of 2% lidocaine 1ml,vitamin B12500 unit for articular cavity.Results:the effective rate of treatment group 95.45%,control group with an efficiency of 40%,two groups have obvious difference.Results:the effect of sodium hyaluronate in the treatment of II~III stage of temporomandibular joint disturbance syndrome significantly.%目的:研究玻璃酸钠、2%利多卡因注射液在治疗27例II~III阶段颞下颌关节紊乱综合症的临床效果分析;方法把27例患者任意分为22例实验组和5例对照组,前者采用玻璃酸钠1 mL(10 mg)、2%利多卡因0.5 mL行患侧关节上腔注射,后者用2%利多卡因1 mL、维生素B12500单位行关节上腔注射。结果治疗组有效率90.90%,对照组有效率40.00%,两组实验有明显差异。结果玻璃酸钠在治疗II~III阶段颞下颌关节紊乱综合症中效果显著。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号